Adenocarcinoma of the Pancreas Recruiting Phase 1 / 2 Trials for Bevacizumab (DB00112)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03193190A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)Treatment
NCT03376659Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic AdenocarcinomaTreatment